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BACKGROUND: Multiple myeloma (MM) therapy is hindered by the interaction of the heterogeneous malignant plasma cells with their
microenvironment and evolving drug resistance. We have previously shown that the membranal tetraspanins, CD81 and CD82, are
under-expressed in MM cells and that their reintroduction causes massive non-apoptotic death. In this study, we aimed to
characterise the tetraspanin-induced MM death.
METHODS: Multiple myeloma cell lines were transiently transfected with eGFP–CD81N1/CD82N1 fusion proteins and assessed for
death mode by flow cytometry (propidium iodide, ZVAD-fmk, 3MA), activation of unfolded protein response (UPR), and autophagy
(immunoblot, RT–PCR).
RESULTS: Cell death induced by CD81N1 and CD82N1 in MM cell lines was autophagic and involved endoplasmic reticulum
(ER)-stress manifested by activation of UPR pathways, PERK (protein kinase-like ER kinase) and IRE1 (inositol-requiring 1). We also
established the relative X-box binding protein 1 baseline expression levels in a panel of MM cell lines and their general dependence
on autophagy for survival. Timeline of UPR cascades and cell fate supported our results.
INTERPRETATION: This is the first publication implicating tetraspanins in UPR signalling pathways, autophagy, and autophagic death.
Integration of our findings with published data highlights the unifying dependence of MM cells on ER–Golgi homoeostasis, and
underscores the potential of tetraspanin complexes and ER-stress as leverage for MM therapy.
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Multiple myeloma (MM) is an incurable malignancy of end-stage B
lymphocytes (plasma cells). Effective disease treatment is
hampered by the complex interactions of the cells with the bone
marrow microenvironment and difficulties in defining genes
that are integral to the malignant phenotype (Anderson, 2007). It
is accepted that effective MM treatment will need to address the
cells in context of their supportive microenvironment, as well
as target compound signalling cascades to overcome cell hetero-
geneity and evolving resistance (Anderson, 2007). A unifying and
unique feature of plasma and MM cells is their extensive protein
synthesis and concomitant cellular adaptations (Barnhart and
Simon, 2007).
Protein synthesis, maturation, assembly, and delivery are
executed in the endoplasmic reticulum (ER) and Golgi apparatus.
Multiple myeloma cells are characterised by expanded ER
(Cenci and Sitia, 2007). Misfolded proteins in the ER are directed
to the proteasome for degradation (ER-associated degradation
– ERAD) (Ding et al, 2007). Insufficient ERAD causes proteins to
accumulate in the ER, induces ER-stress, and activates signalling
cascades. This series of events is termed the unfolded protein
response (UPR). The UPR consists of three major pathways
initiated by GRP78/BiP activation of ER-stress sensors (activating
transcription factor (ATF6), high inositol-requiring 1 (IRE1),
and double-stranded RNA-activated protein kinase-like ER kinase
(PERK)), and ending in transcriptional modifications that promote
the ER capacity for effective protein folding (volume and
chaperones) and diminish the protein synthesis rate (Ron and
Walter, 2007). In fact, recent studies have showed that elevation
of the IRE1-induced transcription factor, X-box-binding protein 1
(XBP1), is essential for terminal B-cell maturation and that
an animal model overexpressing XBP1 developed MM (Reimold
et al, 2001; Carrasco et al, 2007). It was also shown in two MM cell
lines that partial UPR is constitutively activated (Patterson et al,
2008).
Unfolded protein response activation, while having the capacity
to rescue cells by providing a window of opportunity to overcome
the stress source, can also result in cell death when the stress is not
resolved (prolonged and/or too severe) (Ron and Walter, 2007).
The ensuing cell death can be apoptotic, necrotic, autophagic, or a
combination of these. Crosstalk between autophagy and apoptosis
exists as well, resulting in mutual dependence and some
redundancy (Gozuacik and Kimchi, 2007).
Autophagy is a highly regulated process usually activated in
response to adverse environment during which cytoplasmic
materials are enclosed in double membrane-bound vesicles
(autophagosomes) that are then targeted by the lysosome for
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sdegradation. It is an essential process that allows cell conservation
under stress conditions such as nutrient deprivation, and is
implicated in both cell death and survival (Ding et al, 2007).
Previously, we showed that MM cells and cell lines underexpress
tetraspanin members, CD81 and CD82, compared with normal
plasma and peripheral blood B cells (Tohami et al, 2004, 2007;
Drucker et al, 2006). Tetraspanin proteins facilitate the spatial
organisation and localisation of multi-protein complexes in
distinct membranal microdomains that are important to exterior–
interior cell signalling. As molecular coordinators, the tetraspanins
are involved in many fundamental biological pathways and
are correlated with the malignant process and prognosis (Lazo,
2007). The importance of CD81 and CD82 to MM was shown
in a study that reintroduced these tetraspanins in fusion
vectors with eGFP (CD81N1, CD82N1) into MM cell lines. The
tetraspanin overexpression resulted in significant cell death,
described as primarily necrotic and caspase-independent (Tohami
et al, 2007).
In the current study, we aimed to characterise further, the mode
of CD81N1/CD82N1-induced MM death and to delineate the
signals and constituents that are influenced by tetraspanins. Our
major findings showed that the tetraspanins caused ER-stress, UPR
activation, and autophagic cell death. This is the first publication
implicating tetraspanins in autophagic signalling pathways and
autophagic death. Furthermore, our findings underscore the
potential of tetraspanin complexes, ER-stress, and their combina-
tion as possible means for effective MM therapy.
MATERIALS AND METHODS
Cell lines
Multiple myeloma cell lines RPMI 8226 and U266, purchased from
the American Type Culture Collection (ATCC, Manassas, VA,
USA), and ARP1, ARK, and CAG (provided by Professor Epstein
(Little Rock, AR, USA)) were cultured in RPMI 1640 supplemented
with 20% heat-inactivated fetal bovine serum (FBS) and antibiotics
(Biological Industries, Kibbutz Beit Haemek, Israel). PC3 and
Jurkat cell lines (human prostate cancer and T-cell Leukaemia,
respectively) were provided by Collgard Company (Petach Tikva,
Israel) and cultured in RPMI 1640 supplemented with 10% FBS.
Jurkat cells were also supplemented with sodium pyruvate, HEPES
buffer, and nonessential amino acids (Biological Industries).
Transient transfection
Purified plasmids pEGFP-N1 (mock), CD81N1, and CD82N1 were
separately introduced into RPMI 8226 and CAG cells as described
previously (Tohami et al, 2007). Fluorescence (X10000 events
per analysis) was analysed by Coulter Flow Cytometer (FACS)
(EPICS-XL, Beckman Coulter Inc., Fullerton, CA, USA) as detailed
previously (Tohami et al, 2007).
Flow cytometry
Cell survival Transfected and untransfected cells were harvested
18, 24, or 48-h post-treatment/transfection and stained with
1mgml
 1 propidium iodide (PI) for 10min. PI
 /PI
þ cells were
enumerated by FACS. Propidium iodide negative or eGFP
þ/PI
 
were considered the surviving cell fraction (untransfected and
transfected, respectively), whereas the PI
þ and eGFP
þ/PI
þ were
referred to as the fraction of dead cells (untransfected and
transfected, respectively).
Cell death mode RPMI 8226 and CAG cells were incubated
with 0.05mM pan-caspase inhibitor, ZVAD-fmk (R&D systems,
Minneapolis, MN, USA), and/or 10mM autophagy formation
inhibitor, 3-methyladenine (3MA) (Sigma, Rehovot, Israel), an
inhibitor of the class III phosphatidylinositol 3-kinase (Stroikin
et al, 2004), 20mM JNK inhibitor, SP600125 (Biomol Int, Plymouth
Meeting, PA, USA), or 10mM MEK1/2/ERK signalling inhibitor,
U0126 (Cell Signaling Technology, Danvers, MA, USA), (all
dissolved in DMSO) 4 hours after 81N1 and 82N1 transfection.
Cell survival (eGFP
þ/PI
– cells) was determined 18, 24, or 48h
post-transfection by flow cytometry. Untreated 81N1- and 82N1-
transfected cells were considered as controls.
Cell sorting
Transiently transfected cells were harvested 18 or 24h post-
transfection and passed several times through a syringe for clump
dispersion. Next, eGFP
þ and eGFP
  cells (5 10
6cells per ml in
PBS supplemented with 10% FBS) were isolated and collected
using a BD FACSAria cell sorter (BD Biosciences, Sparks, MD,
USA). Matching cells treated with respective transfection reagent
only, were considered eGFP
  and used for calibration of eGFP
þ
cell threshold.
Western blotting
eGFP
þ-sorted cells were lysed in a lysis buffer containing 50mM
HEPES, 150mM NaCl, 1% Triton X-100, 0.1% SDS, 50mM NaF,
10mM NaPPi, 2mM NaVO3,1 0 m M EDTA, 2mM EGTA, 1mM
PMSF, and 10mgml
 1 Leupeptin, for 10min on ice. The
autophagosome-related MAP LC3 protein (LC3I and its modified
form LC3II) were detected with a rabbit polyclonal antibody
(1:2000 dilution, Sigma). Rabbit anti-pJNK (Thr183/Tyr185), total
JNK, pmTOR (Ser2448), total mTOR, Beclin 1, and GRP78/BiP
(1:1000 dilution) were all from Cell Signaling Technology. Rabbit
anti-GADD34 (1:1000) and GADD153/CHOP (1:500) were from
Santa Cruz (Santa Cruz, CA, USA). Protein samples of 300000 cells
each were mixed 1:5 with loading buffer, separated by SDS–
PAGE, and transferred to a nitrocellulose/PVDF membrane. After
blocking non-specific binding sites with 5% milk powder,
membranes were treated with primary antibodies at 41C overnight.
Bound antibodies were visualised using peroxidase-conjugated
secondary antibody (1:10000; Jackson ImmunoResearch Labora-
tories, West Grove, PA, USA; 75min at room temperature),
followed by enhanced chemiluminescence (ECL) detection (ECL
kit, Santa Cruz or Pierce, Rockford, IL, USA). Products were
visualised with LAS3000 Imager (Fujifilm, Greenwood, SC, USA).
Integrated optical densities of the immunoreactive protein bands
were measured as arbitrary units employing Multi Gauge software
(Fujifilm).
Reverse transcription polymerase chain reaction
Total RNA was extracted from 18, 24, or 48-h transfected cells with
Purescript (Gentra Systems, Minneapolis, MN, USA). Total RNA
(1mg) was reverse transcribed (Reverse-iT 1st strand synthesis kit,
ABgene, Epsom, UK) and amplified for XBP1/XBP1s and house-
keeping b-actin (3 and 1.5ml cDNA, respectively). The PCR was
optimised at 941C for 2min, followed by 38 cycles of 15s at 941C,
60s at 601C, and 30s at 721C, using 4pmol XBP1/XBP1s primers
(F, 50-CCTTGTAGTTGAGAACCAGG-30 and R, 50-GGGGCTT
GGTATATATGTGG-30) and 2pmol b-actin primers (F, 50-GAG
ACCTTCAACACCCCAGC-30 and R, 50-GCTCATTGCCAATGGT
GATG-30). Products were electrophoresed on 2.2% agarose gels
stained with ethidium bromide and visualised with Gel Doc 2000
and Multi-analyst software (Bio-Rad, Hercules, CA, USA).
Amplification products of XBP1 observed in gels included the
spliced, unspliced, and hybrid (duplex of full-length and spliced)
forms (Lin et al, 2007). Spliced XBP1 was calculated from the sum
of quantified XBP1s band and half the quantity of the hybrid form;
total XBP1 was deduced from the combined sum of all bands.
X-box binding protein 1/XBP1s expression was normalised to
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srespective b-actin. Average expression of all myeloma and non-
myeloma cell lines was calculated (arbitrary units) and statistically
compared. CD81N1/CD82N1 samples were compared with mock
(N1)-transfected controls and ratios were expressed as fold change.
Statistical analysis
Paired Student’s t-tests were used to analyse differences between
cohorts. A P-value of less than or equal to 0.05 was considered
significant. An antagonistic effect was verified by drugs’ inter-
action formula q¼P(AþB)/P(A)þP(B) P(A) P(B) (qo0.85 
antagonist; q41.15 – synergist; 1.154q40.85 – additive) (Su et al,
2004) assuming that tetraspanin’s transfection is the first treatment
(A) and 3MA treatment is the second (B). All experiments were
repeated separately three to seven times.
RESULTS
Previously we have reported that reintroduction of the tetra-
spanins, CD81N1 and CD82N1, into CAG and RPMI 8226 MM cell
lines resulted in significant non-apoptotic cell death compared
with mock-transfected cells (Tohami et al, 2007). Acknowledging
the necessity of MM cells to incur changes that support the
intensive protein synthesis and ER–Golgi equilibrium typical to
them, we hypothesised that the tetraspanins’ effect may involve an
autophagic form of cell death due to ER-stress and UPR activation.
The relevance of our hypothesis was preliminarily tested by
addressing the activation of UPR and autophagy in MM cell lines’
panel (untransfected).
Autophagy facilitates basal MM cell lines survival
We assessed the importance of autophagy to MM cell lines
homoeostasis. We found that inhibiting autophagosome formation
using 3MA resulted in elevated levels of cell death (up to
10%, Po0.05) in all MM cell lines (Figure 1A), but not in the
prostate cancer and T-cell leukaemia cell lines (PC3 and Jurkat,
respectively).
We also determined XBP1 transcript level in MM cell lines and
established a relative baseline for further reference (Figure 1B and C).
All myeloma cell lines express detectable levels of total XBP1
(mean¼0.6) that are significantly higher than non-myeloma cell
lines (PC3, Jurkat) (mean¼0.41, Po0.05), which is in agreement
with published data (Carrasco et al, 2007; Patterson et al, 2008).
The connection between ER-stress and activation of UPR and the
induction of autophagy is well established, yet autophagy may
function as a means of cell preservation as well as a mechanism of
cell death (Ogata et al, 2006; Ding et al, 2007). Moreover, it was
shown that increased autophagy levels in yeast facilitate the removal
of excess ER after UPR activation, thus promoting ER-homeostasis
(Kincaid and Cooper, 2007). Taken together, our results indicate
that MM cell lines display a general dependency on autophagy for
survival, which may be maintained through a basal condition of
ER-stress and activation of UPR signalling cascades.
Autophagic death induced by CD81N1 and CD82N1 in MM
cell lines
Next, we examined the mode of cell death induced by
CD81N1/CD82N1 in RPMI 8226 and CAG cells. Transfected cells
supplemented with 3MA displayed a significant B25% (Po0.05)
rescue from cell death of CD81N1- and CD82N1-transfected RPMI
8226 cells (48h) and 12% rescue in CD81N1-transfected CAG cells
(24h) (Po0.05, qo0.85) compared with transfected cells not
supplemented with 3MA (Figure 2A). In addition, a significant
elevation in the proportion of LC3II (vs LC3I) compared with the
mock control was observed in CD81N1/CD82N1-transfected RPMI
8226 (24h) and CD81N1-transfected CAG cells (18h) (35–45%,
Po0.05, Figure 2B). Our results also display significant increases in
absolute LC3II levels (not relative to LC3I) compared with mock-
transfected cells in CD81N1-transfected RPMI 8226 (38%) and CAG
cells (60%), and in CD82N1-transfected RPMI 8226 cells (34%)
(Po0.05), an analysis method suggested to be more reliable for
determining autophagy (Mizushima and Yoshimori, 2007). It should
be noted that CD82N1-transfected CAG cells did not display an
increase in LC3II (absolute and relative), nor did they respond
to 3MA compared with the mock control, all in accordance with a
non-autophagic cell death mode (Figure 2A and B). Next, we
co-administered the caspase inhibitor, ZVAD, to tetraspanin-
transfected MM cell lines treated with 3MA (data not shown). The
combined application of 3MA and ZVAD did not differ from
CD81N1/CD82N1-transfected cells treated with 3MA alone, indicat-
ing that there was no shift in the death mode of the MM cell lines
when the autophagy and/or apoptotic cascades were blocked.
For additional validation of autophagic modulation, we
examined levels of the established inhibitor of autophagy, mTOR,
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Figure 1 Multiple myeloma cell lines’ basal levels of total XBP1 and
dependence on autophagy. (A) Cancer cells lines (x-axis) treated with/
without autophagy inhibitor 3MA (10mM) for 24h were assessed for cell
death by FACS (10000 events) employing PI exclusion assay. Propidium
iodide negative cells were considered viable and PI
þ were regarded as
dead cells. Results are expressed as mean proportion of PI
þ cells per total
cell count±s.e. (y-axis) of at least four separate experiments. Statistically
significant differences (Po0.05) are indicated by *. (B) An exemplary
picture of XBP1 and b-actin (depicted on the left) semi-quantitative RT–
PCR conducted on a panel of cell lines (designated on top) and separated
by electrophoresis on a 2.2% agarose gel stained with ethidium bromide.
(C) Graphic presentation of total XBP1 in cancer cell lines (x-axis). Semi-
quantitative RT–PCR of total XBP1 was normalised to housekeeping
b-actin in each sample. Results are expressed as mean±s.e. of at least
three separate experiments. Statistically significant differences (Po0.05) are
indicated by *.
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swhich normally converts metabolic and mitogenic signals into
protein synthesis, and is a recognised target in MM therapeutics
(Hu et al, 2003). Assessment of phosphorylated and total mTOR
levels in CD81N1/CD82N1-transfected MM cell lines displayed
decreased levels of active mTOR compared with mock-transfected
control (24h post-transfection, 35–40%, Po0.05), which is in sync
with autophagic activation (Figure 2C). These findings are also in
accordance with previous results that described a decrease in the
number of tetraspanin-transfected MM cells expressing pmTOR
(Lishner et al, 2008).
Next, we assessed cellular levels of Beclin 1, an established
component of the autophagic machinery (Cao and Klionsky, 2007),
in the tetraspanin vs mock-transfected MM cell lines, but failed to
determine significant changes (data not shown). Interestingly,
several recent publications present evidence of a ‘Beclin-indepen-
dent autophagic pathway’ distinguished with an ERK and/or
JNK-induced autophagy (Chu et al, 2007; Dagda et al, 2008).
Therefore, we examined the importance of ERK and JNK signalling
to transfected MM cells. Inhibition of MEK/ERK resulted in
increased cell survival of CD81N1-transfected RPMI 8226 and CAG
cells (24h post-transfection, B1.26-fold change, Po0.05) as did
inhibition of JNK, which resulted in increased survival of CD81N1-
transfected RPMI 8226 (48h) and CAG cells (24h) (1.45- and 3.18-
fold change, respectively; Po0.05) and of CD82N1-transfected
RPMI 8226 cells (24h, 1.27-fold change; Po0.05) (Figure 3). The
involvement of JNK in the death of CD81N1-transfected CAG cells
was reported by us previously in association with activation of
Forkhead box O (FoxO) (Lishner et al, 2008).
Increased ER-stress and UPR signalling in CD81N1/
CD82N1-transfected MM cell lines
Given that autophagy may be activated by ER-stress, we decided to
examine whether this was the case in our research model. Analysis
of UPR signalling in the tetraspanin-transfected MM cell lines
showed a common activation. We assessed levels of the ER-stress
sensor, GRP78/BiP, the IRE1 pathway components, XBP1s and
pJNK (Thr183/Tyr185), and the PERK pathway components, XBPt,
GADD34, and GADD153/CHOP (Ron and Walter, 2007). Signifi-
cant changes indicative of IRE1 and PERK activation compared
with mock-transfected control were determined in both CD81N1-
and CD82N1-transfected RPMI 8226 (24h post-transfection) and
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Figure 2 CD81N1/CD82N1 induce autophagic cell death in MM cell lines. RPMI 8226 and CAG cells (depicted at the top) were transiently transfected
with N1 (mock), CD81N1, or CD82N1 (x-axis) and assessed for autophagy death mode. (A) Transfected cell lines RPMI 8226 (48h post-transfection) and
CAG (24h) with/without autophagy inhibitor 3MA (10mM) were assessed for survival by FACS. Results are calculated as the proportion of surviving
transfected cells (eGFP
þ/PI
 ) in each sample and expressed as the mean relative percentage±s.e. compared with total eGFP
þ mock-transfected cells.
Statistically significant (Po0.05) differences are indicated as *, antagonistic changes indicated by $ (qo0.85). At least three separate experiments in duplicate
were conducted and FACS recorded 10000 events. (B) Representative immunoblot (300000cells per lane) of LC3 (I and II depicted by arrows in central
panel) and densitometry of at least three separate experiments are presented (mean±s.e.). LC3II/LC3I were normalised to mock N1 and expressed as fold
change. Statistically significant differences (*Po0.05) are depicted. (C) Representative immunoblot of mTOR and pmTOR (Ser2448) (central panel)
(300000 cells per lane) and densitometry of at least three separate experiments are presented (mean±s.e.). pmTOR/mTOR were normalised to mock N1
and expressed as fold change. Statistically significant differences (*Po0.05) are depicted.
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were detected 24h post-transfection) (Figure 4).
Specifically, in CD81N1-transfected RPMI 8226 and CD82N1-
transfected CAG cells, increased BiP was detected (88 and 32%,
respectively; Po0.05). Increased XBPs (20–100%) and pJNKs
(37–230%) were shown using both tetraspanin vectors in RPMI
8226 and CAG cells (Po0.05). Increased levels of XBP1t (30–
200%) and GADD34 (37–56%) were shown in CD81N1-transfected
RPMI 8226 cells and in both cell lines transfected with CD82N1
(Po0.05). Increased levels of XBP1t (19%) and CHOP (25%) were
determined in CD81N1-transfected CAG cells (Po0.05).
In summary (Table 1), these results show several facets of UPR
activation and, therefore, substantiate increased ER-stress in the
tetraspanin-transfected MM cell lines. The consequential cell death
was mostly autophagic except for the CD82N1-transfected CAG
cells, which display ER-stress, yet their death mode is necrotic (by
elimination: not autophagic (Figure 2) and not apoptotic (Tohami
et al, 2007)).
Timeline of tetraspanin-induced UPR and cell death in MM
cell lines
The feasibility of our findings is further confirmed by the timeline
of UPR signalling and ensuing death (Figures 5 and 6), which is
compatible with the model presented recently by Lin et al (2007).
Lin and co-authors presented that the initial combined activation
of IRE1, PERK, and ATF6 produces cytoprotective outputs
(reduced translation, enhanced ER protein folding capacity),
which provide a ‘window of opportunity’ for cells to readjust
their ER to cope with stress. If these steps fail to re-establish
homoeostasis, IRE1 signalling followed by ATF6 signalling is
attenuated, creating an imbalance in which an unchecked PERK
pro-apoptotic output channels the cell towards its termination
(Lin et al, 2007). Figure 5 shows a temporary increase in XBP1s
(Po0.05) and continued elevation of XBP1t in CD81N1/CD82N1-
transfected MM cell lines. In Figure 6, we present a sequential
alignment of UPR markers with cell fate. Inositol-requiring 1 and
PERK activation was determined 24/18h after tetraspanins’
transfection in RPMI 8226 and CAG cells, respectively. At 48/
24h post-transfection, PERK activation was still maintained in
RPMI 8226 and CAG cells, respectively, whereas IRE1 activity had
already decreased. At this time point, we also determined JNK
activation and showed significant cell death. In addition, pJNK
levels were not elevated at earlier time points (24h in RPMI 8226
and 18h in CAG cells) and, therefore, are in accordance with its
activation in IRE1 progression and onset of cell death (Figure 6
and data not shown).
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Figure 3 Involvement of ERK and JNK in CD81N1/CD82N1-induced MM cell death. Cell survival of CD81N1/CD82N1 transiently transfected RPMI
8226 (A) and CAG (B) cells with/without 20mM JNK inhibitor SP600125 (48 and 24h post-transfection, respectively) or 10mM MEK1/2/ERK signalling
inhibitor U0126 (24h) was measured by FACS. Results are calculated as the proportion of surviving transfected (eGFP
þ/PI
 ) cells in each sample and
expressed as the mean relative percentage±s.e. compared with total eGFP
þ mock-transfected cells. N1/81N1/82N1 transfections with treatment
(SP600125 or U0126) were normalised to untreated transfection and expressed as fold change. Statistically significant differences (*Po0.05) are indicated.
At least three separate experiments in duplicate were conducted, and FACS recorded 10000 events.
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Figure 4 Activated UPR signalling in transfected MM cell lines. RPMI
8226 and CAG cells were transfected with N1, CD81N1, and CD82N1
and assayed 18/24h later (detailed in Result section). Unfolded protein
response components were detected by immunoblot (BiP, JNK, GADD34,
CHOP) or semi-quantitative RT–PCR (XBP spliced (XBPs) and XBP total
(XBPt)). Graphic presentations (mean±s.e.) of densitometry (NX3) of
RPMI 8226 81N1 (A) 82N1 (B), and CAG 81N1 (C) 82N1 (D) (indicated
on the left of each panel) cells are presented. Representative immunoblots
(300000cells per lane) and an exemplary picture of XBP1 RT–PCR are
presented in the right side of each panel. BiP, pJNK/JNK, GADD34, and
CHOP were normalised to mock N1 and expressed as fold change.
Arrows in XBP RT–PCR picture depict the unspliced (u), spliced (s) and
hybrid (%) forms. Expression levels were normalised to b-actin, fold
changes were calculated in total and spliced XBP1 levels relative to mock
and expressed as mean±s.e. of at least four separate experiments.
Statistically significant differences (*Po0.05, **Po0.01) are depicted.
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sDISCUSSION
The primordial function of autophagy has long been recognised,
but its significance in multiple cellular roles and various
pathological conditions, including cancer, is only now being
revealed (Gozuacik and Kimchi, 2007; Lerena et al, 2008;
Mizushima et al, 2008). In this study, we showed that MM cell
lines rely on autophagy for their survival and proliferation under
normal culture circumstances. This was not evident in cell lines of
other origins. The propensity of MM cells for increased autophagic
activity is consistent with the published data that established
their heightened ER-stress levels and the functional relationship
between the two states (Cenci and Sitia, 2007). Despite the
survival-promoting role of the basal autophagy, which we
determined, it is well recognised that elevated and/or prolonged
autophagy can culminate in cell death (Gozuacik and Kimchi,
2007; Galluzzi et al, 2008), a prospect of great significance in the
death of resistant myeloma cells.
In this study, we establish that autophagic death is an achievable
target in MM cell lines. We showed that tetraspanins induced ER-
stress, manifested by activation of UPR pathways, increased
autophagy, and eventually, cell death. Moreover, chronological
alignment of UPR pathways’ expression, shutdown, and ensuing
cell death is in agreement with the mechanism of cell fate
regulation allocated with the UPR (Lin et al, 2007). The
achievability of autophagic death in MM is strengthened by a
recent study that reported that inhibition of p27 expression in MM
caused death by autophagy (Chen et al, 2008). Yet, in this study,
death was preceded by cell cycle arrest, whereas our experimental
setting displayed no such effect (Tohami et al, 2007). Previously,
we showed that the CD81N1/CD82N1 overexpression attenuated
AKT activity and activated FoxO transcription factors (Lishner
et al, 2008). In this project we again showed the involvement of
JNK activity in the fate of transfected cells (Lishner et al, 2008).
Taken together, these findings are compatible with a recent
publication that depicted a role for FoxO1 in the death of ER-
stressed macrophages (Senokuchi et al, 2008). Interestingly,
Senokuchi and colleagues showed that FoxOs failed to induce cell
death in the absence of ER-stress. The involvement of JNK in ER-
stress response, as well as in the regulation of FoxO proteins has
been described extensively (Ogata et al, 2006; Huang and Tindall,
2007; Lim et al, 2009).
The connection of tetraspanin circuitry with ER-stress and
autophagy is novel and provides a direct link between the
cancer microenvironment and fundamental cellular functions. In
particular, positioning the tetraspanins up-stream of ER–Golgi
homoeostasis underscores the significance of the integration of
metabolic, environmental, and mitogenic cues to MM survival.
The biological validity of our experimental system is substan-
tiated by multiple controls. In both the current and in previous
Table 1 Summary of CD81N1/CD82N1-induced effects in MM cell lines
Model UPR Cell death mode Cell death rescue
Cell line Tetraspanin IRE PERK Necrosis (PI
+cellsm) Autophagy (LC3IIm) 3MA MAPK (JNK/ERK) inhibition
8226 81N1 OO O O O O
8226 82N1 OO O O O O
CAG 81N1 OO O O O O
CAG 82N1 OO O     
Abbreviations: ERK¼extracellular signal-regulated kinase; IRE¼inositol-requiring 1; JNK¼c-Jun N-terminal kinases; MA¼methyladenine; MAPK¼mitogen-activated protein
kinase; MM¼multiple myeloma; PERK¼protein kinase-like ER kinase; PI¼propidium iodide; UPR¼unfolded protein response.O , An effect was found.  , no effect was
evident. (Detailed in the results).
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Figure 5 Fate of UPR signalling. Temporary increase in XBP1s (indicative of IRE1 pathway) and continued elevation of XBP1t (indicative of PERK
pathway) in RPMI 8226 81N1 (A) 82N1 (B), and CAG 81N1 (C) and 82N1 (D) cells are presented. X-box binding protein spliced and total were detected
by semi-quantitative RT–PCR. Expression levels of XBP1s and XBP1t were normalised to b-actin, fold changes were calculated relative to mock and
expressed as mean±s.e. of at least three separate experiments. Statistically significant differences (*Po0.05) are depicted.
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s(Tohami et al, 2007; Lishner et al, 2008) studies, we showed that cell
death, as well as the activation of UPR pathways, can be determined
only in MM cell lines transfected with CD81N1 and CD82N1 eGFP
fusion vectors and not with the empty eGFP construct (mock) or
with the CD81C1 and CD82C1 oriented fusion plasmids (Tohami
et al, 2007). Taken together, our results can be interpreted as
presenting specific signals initiated by the cloned tetraspanins (in
their N1 conformation). Concurrent with this line of thought,
studies underway in our laboratory are examining the possible
involvement of phosphatidylinositol 4 kinase type II (PI4KIIa/b)b y
direct or indirect (through other tetraspanin members) association
with CD81N1/CD82N1. Phosphatidylinositol 4 kinase type II-a is a
particularly attractive target because it is one of the few signalling
molecules known to bind to tetraspanins and it is critically
important for ER–Golgi homoeostasis. Moreover, its product, the
phosphatidyl inositol-4-phosphate, functions as a docking/binding
domain for multiple proteins (Weixel et al,2 0 0 5 ;M a t t e i sa n d
D’Angelo, 2007). The differential association of CD81 (binding) and
CD82 (non-binding) (Yauch and Hemler, 2000) to PI4KII and the
presence of CD81 in RPMI 8226 cells may result in diverse
tetraspanin microdomains (qualitatively and quantitatively).
Our results can also be viewed from a totally different
perspective. It is possible that ER-stress and autophagy death are
instigated by the sheer burden of protein synthesis and trafficking,
regardless of any specific signals that may originate from the
tetraspanin fusion protein. It should also be taken into account
that CD81/CD82 eGFP fusion proteins are regulated by the
powerful CMV promoter, and that MM cells are already in a sensi-
tised state of elevated protein synthesis and increased IRE/XBP1
expression. The differences between the pEGFP-N1-oriented
plasmids and the empty or pEGFP-C1-oriented cloned tetraspanins
may be attributed to decreased efficiency of folding and/or
trafficking. If so, the transfected proteins would accumulate in
the ER and eventually cause stress. Proof-of-concept will indicate
that the mere burdening of ER–Golgi function may present
a therapeutic target in protein-secreting cells such as myeloma.
The effect of CD81N1 and CD82N1 on protein synthesis in the
transfected MM cell lines is currently under investigation in our
laboratory.
Targeting protein synthesis and secretion in MM has
been addressed previously (Carew et al, 2006; Nakamura et al,
2006; Davenport et al, 2007; Patterson et al, 2008). Several
drugs abrogating ER–Golgi stability have been used in vitro to
induce MM cell death. In addition, a recent publication reported
that the proteosome inhibitor, Bortezomib, used clinically
causes protein accumulation in the ER by blocking ERAD as one
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Figure 6 Timeline of UPR signalling and cell death. The figure presents the activation sequence of IRE1, PERK, JNK, and cell death of CD81N1/CD82N1-
transfected RPMI 8226 and CAG MM cell lines. Inositol-requiring 1 and PERK were determined by semi-quantitative RT–PCR of XBP1s and total XBP1,
respectively; JNK activation was deduced from rescue of tetraspanin-transfected cells (relative mock) by SP600125; and cell death was analysed by FACS
based on PI exclusion of eGFP
þ cells. The A panel is a schematic presentation and the B panel depicts mean fold change±s.e. of IRE1, PERK, and cell death
(depicted in the legend under the graphs) relative to mock at different time points (x-axis). Significant elevation of IRE1 and PERK were at 24h/18h post-
transfection in RPMI 8226 and CAG MM cells, respectively (Po0.05). As time progressed (48h/24h post-transfection in RPMI 8226 and CAG cells,
respectively), it can be determined that, although IRE1 splicing of XBP1 was diminished, the PERK-regulated expression of total XBP1 was maintained.A t
least three separate experiments were conducted at each time point.
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sof its action modes (McCloskey et al, 2008). Our findings
suggest the possibility that ER-stress may be achieved by increased
protein synthesis and interestingly, this may be the path of least
resistance, because it is in sync with built-in MM characteristics,
hence the ‘Achilles’ heel’ of these cells. Future studies will be
needed to determine effective ways to induce catastrophically
elevated and clinically achievable protein synthesis for therapeutic
purposes.
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